[EN] FUSED RING NK1 ANTAGONISTS<br/>[FR] ANTAGONISTES DE NK1 A CYCLES FUSIONNES
申请人:SCHERING CORP
公开号:WO2005100358A1
公开(公告)日:2005-10-27
A compound having the general structure shown in Formula (1) or pharmaceutically acceptable salts and/or solvates thereof are useful in treating diseases or conditions mediated by NK1 receptors, for example various physiological disorders, symptoms or diseases, including emesis, depression, anxiety and cough.